<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151300">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01842789</url>
  </required_header>
  <id_info>
    <org_study_id>CP-00-0021</org_study_id>
    <nct_id>NCT01842789</nct_id>
  </id_info>
  <brief_title>Post Market Evaluation of Acessa With TAG</brief_title>
  <acronym>TAG</acronym>
  <official_title>Post Market Evaluation of the Acessa System With Targeting Animation Guidance (TAG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Halt Medical, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Halt Medical, Inc</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test both user preference and speed of targeting with the
      use of the Acessa System with Targeting Animation Guidance (TAG).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The intent of the TAG system is to assist the gynecologist in getting the tip of the Acessa
      Handpiece to the fibroid by creating an animated image overlay of the movements and
      placement.

      The study will be conducted in two parts:

      Part 1: User Preference Testing - users will be presented with various statements pertaining
      to the features of the system and asked to indicate their degree of agreement.

      Part 2: Time to target -  will be measure by fibroid.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Physician interface and preference with and without TAG</measure>
    <time_frame>Up to 1 hour post-treatment</time_frame>
    <safety_issue>No</safety_issue>
    <description>To obtain feedback on the user interface of the Acessa System with TAG through physician preference testing using a direct, observable human model. This will be assessed  by the completion of a questionnaire using a 5 point rating system ranging from &quot;strongly agree&quot; to &quot;strongly disagree&quot; regarding the ease of targeting, specific features of the system, user interface and set-up.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to Target</measure>
    <time_frame>Intraoperative</time_frame>
    <safety_issue>No</safety_issue>
    <description>To measure difference in time to target with and without the use of TAG. This is a time and motion study, with time measured from puncture of the serosal surface to the fibroid capsule.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recovery Time</measure>
    <time_frame>30 Days Post-Treatment</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients to be followed 30 day post-treatment to evaluate recovery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Uterine Fibroids</condition>
  <arm_group>
    <arm_group_label>Acessa Procedure w/o TAG</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Acessa Procedure without the use of Targeting Animation Guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acessa Procedure with TAG</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Acessa Procedure with Targeting Animation Guidance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acessa Procedure</intervention_name>
    <description>Acessa Procedure</description>
    <arm_group_label>Acessa Procedure w/o TAG</arm_group_label>
    <arm_group_label>Acessa Procedure with TAG</arm_group_label>
    <other_name>TAG</other_name>
    <other_name>Acessa Procedure</other_name>
    <other_name>Halt Procedure</other_name>
    <other_name>GFA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Women who:

          -  Are planning to undergo the Acessa procedure

          -  Are willing and able to comply with all procedures

          -  Are capable of providing informed consent

        Exclusion Criteria: Women who:

          -  In the medical judgement of the investigator should not participate in this study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald I Galen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Donald I Galen Consulting</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Micah Harris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Women's Health Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Women's Health Research</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Donald I Galen Consulting</name>
      <address>
        <city>San Ramon</city>
        <state>California</state>
        <zip>94583</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hayhurst C, Byrne P, Eldridge PR, Mallucci CL. Application of electromagnetic technology to neuronavigation: a revolution in image-guided neurosurgery. J Neurosurg. 2009 Dec;111(6):1179-84. doi: 10.3171/2008.12.JNS08628.</citation>
    <PMID>19326991</PMID>
  </reference>
  <reference>
    <citation>Fried MP, Parikh SR, Sadoughi B. Image-guidance for endoscopic sinus surgery. Laryngoscope. 2008 Jul;118(7):1287-92. doi: 10.1097/MLG.0b013e31816bce76. Review.</citation>
    <PMID>18391767</PMID>
  </reference>
  <reference>
    <citation>Krucker J, Xu S, Glossop N, Viswanathan A, Borgert J, Schulz H, Wood BJ. Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. J Vasc Interv Radiol. 2007 Sep;18(9):1141-50.</citation>
    <PMID>17804777</PMID>
  </reference>
  <reference>
    <citation>Garza Leal JG, Hernandez Leon I, Castillo Saenz L, Lee BB. Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System. J Minim Invasive Gynecol. 2011 May-Jun;18(3):364-71. doi: 10.1016/j.jmig.2011.02.006.</citation>
    <PMID>21545960</PMID>
  </reference>
  <reference>
    <citation>Bergamini V, Ghezzi F, Cromi A, Bellini G, Zanconato G, Scarperi S, Franchi M. Laparoscopic radiofrequency thermal ablation: a new approach to symptomatic uterine myomas. Am J Obstet Gynecol. 2005 Mar;192(3):768-73.</citation>
    <PMID>15746670</PMID>
  </reference>
  <reference>
    <citation>Milic A, Asch MR, Hawrylyshyn PA, Allen LM, Colgan TJ, Kachura JR, Hayeems EB. Laparoscopic ultrasound-guided radiofrequency ablation of uterine fibroids. Cardiovasc Intervent Radiol. 2006 Jul-Aug;29(4):694-8.</citation>
    <PMID>16502165</PMID>
  </reference>
  <reference>
    <citation>Robles R, Aguirre VA, Argueta AI, Guerrero MR. Laparoscopic radiofrequency volumetric thermal ablation of uterine myomas with 12 months of follow-up. Int J Gynaecol Obstet. 2013 Jan;120(1):65-9. doi: 10.1016/j.ijgo.2012.07.023. Epub 2012 Oct 14.</citation>
    <PMID>23073229</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 14, 2014</lastchanged_date>
  <firstreceived_date>April 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acessa</keyword>
  <keyword>Fibroids</keyword>
  <keyword>Halt</keyword>
  <keyword>Targeting Animation</keyword>
  <keyword>Image Overlay</keyword>
  <keyword>Radiofrequency Ablation</keyword>
  <keyword>RFA</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
